Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Epoprostenol 1.5mg powder and solvent (pH12) for solution for infusion vials |
| BNF code | 0208010E0AAAEAE |
| Virtual Therapeutic Moiety | Epoprostenol |
| Abbreviated name | Epoprostenol 1.5mg (pH12) inf vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Epoprostenol sodium |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372513003 |
| Strength value numerator | 1.500 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninfusion.intravenous |
| Dose Form | |
| Formulation | Powder and solvent for solution for infusion |
| Drug Route | |
| Route | Intravenous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Epoprostenol 1.5mg powder and solvent (pH12) for solution for infusion vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.